GRK2 is a novel early marker of cardiotoxicity in response to doxorubicin

28 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Basic Science - Autoimmune/Chronic Inflammatory Disorders and Heart Disease Autoimmune/Chronic Inflammatory Disorders and Heart Disease HFA Premium Access Heart Failure 2018

ESC 365 is supported by

ESC 365 is supported by